Example: Heart Attack

Clinical Trials on Angiomyolipoma

Total 15 results

NCT01217125

Completed

Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis

Conditions: Angiomyolipoma
NCT02539459

Terminated

Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus

Conditions: Sporadic Angiomyolipomas (AMLs)
NCT03525834

Completed

Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

Conditions: Renal Angiomyolipoma
NCT02104011

Completed

Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers

Conditions: Renal Angiomyolipomas; Tuberous Sclerosis
NCT02325505

Recruiting

Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma

Conditions: Tuberous Sclerosis; Lymphangioleiomyomatosis; Angiomyolipoma
NCT00126672

Unknown status

Sirolimus in Treating Patients With Angiomyolipoma of the Kidney

Conditions: Nonmalignant Neoplasm
NCT02887781

Recruiting

Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France

Conditions: Tuberous Sclerosis Complex
NCT00790400

Completed

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Conditions: Tuberous Sclerosis Complex (TSC); Lymphangioleiomyomatosis (LAM)
NCT00457964

Completed

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

Conditions: Tuberous Sclerosis; Lymphangioleiomyomatosis
NCT00792766

Completed

Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)

Conditions: Tuberous Sclerosis; Angiolipoma
NCT03477149

Completed

EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications

Conditions: Varicocele; Endoleak; Portal Vein Thrombosis; Bleeding; Angiomyolipoma
NCT00457808

Completed

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

Conditions: Tuberous Sclerosis; Lymphangioleiomyomatosis
NCT02654340

Recruiting

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Conditions: Hypomelanotic Macules; Facial Angiofibroma; Shagreen Patches; Ungual Fibromas; Cortical Dysplasia; Cardiac Rhabdomyoma; Lymphangioleiomyomatosis; Renal Angiomyolipoma; Subependymal Giant Cell Astrocytoma
NCT00598455

Completed

Tuberous Sclerosis Complex Natural History Study: Renal Manifestations

Conditions: Tuberous Sclerosis Complex
NCT01690871

Withdrawn

A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa

Conditions: Malignant PEComa (Perivascular Epithelioid Cell Tumors)